Stockscreener 앱 받기
2.91
2.28%
0.065
시간 외 거래:
2.91
Relay Therapeutics Inc 주식(RLAY)의 최신 뉴스
What Makes Relay Therapeutics (RLAY) a New Buy Stock - Yahoo Finance
Northern Trust Corp Buys 231,713 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
BNP Paribas Financial Markets Invests $987,000 in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Stifel Financial Corp Makes New Investment in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Layoff Tracker: Allogene Cuts 28% of Staff to Extend Runway, Focus on Clinical Programs - BioSpace
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Transcript : Relay Therapeutics, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 03 - marketscreener.com
Relay Therapeutics, Inc. (RLAY): One of the Best Low Priced Biotech Stocks to Buy Now - Yahoo Finance
10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey
HC Wainwright Issues Optimistic Forecast for RLAY Earnings - Defense World
Relay Therapeutics, Inc. (RLAY): A Bull Case Theory - MSN
89,949 Shares in Relay Therapeutics, Inc. (NASDAQ:RLAY) Purchased by First Trust Advisors LP - Defense World
Dimensional Fund Advisors LP Grows Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Q2 EPS Estimate for Relay Therapeutics Lowered by Analyst - Defense World
Relay Therapeutics to Participate in Two Upcoming Investor Conferences - The Manila Times
Hsbc Holdings PLC Has $458,000 Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - The AM Reporter
MetLife Investment Management LLC Grows Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Guggenheim Lowers Price Target for Relay Therapeutics (RLAY) to $10.00 | RLAY Stock News - GuruFocus
Relay Therapeutics (RLAY) Stock Target Reduced Amid Strategic Changes and Progress | RLAY Stock News - GuruFocus
Marshall Wace LLP Lowers Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Raymond James Financial Inc. Takes $779,000 Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Wells Fargo & Company MN Decreases Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics Inc (RLAY) Q1 2025 Earnings: EPS Loss of $0.4 - GuruFocus
Relay Therapeutics (RLAY) Reports Decline in Q1 Revenue | RLAY S - GuruFocus
Relay Therapeutics Extends Cash Runway and Advances Clinical Trials - TipRanks
Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates | RLAY Stock News - GuruFocus
Relay Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Relay Therapeutics, Inc. SEC 10-Q Report - TradingView
Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates - The Manila Times
Relay Therapeutics Extends Cash Runway into 2029 Amid Clinical Trial Advancements - Nasdaq
Barclays PLC Has $1.29 Million Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Invesco Ltd. Acquires 5,261 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
There Is A Lot Of Upside Potential For Relay Therapeutics Inc(NASDAQ: RLAY) - Stocksregister
why Relay Therapeutics Inc [RLAY] is a Good Choice for Investors After New Price Target of $17.40 - dbtnews.com
Relay Therapeutics executive sells $36,540 in stock By Investing.com - Investing.com Nigeria
Relay Therapeutics executive sells $36,540 in stock - Investing.com Australia
LPL Financial LLC Sells 6,564 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics president sells $95,381 in stock By Investing.com - Investing.com South Africa
Relay Therapeutics chief legal officer sells $44,040 in stock By Investing.com - Investing.com South Africa
Relay Therapeutics CFO sells shares worth $44,246 By Investing.com - Investing.com South Africa
Relay Therapeutics Inc Stock: Executives Sell Shares Amid Mixed Signals - sharewise
Relay Therapeutics president sells $95,381 in stock - Investing.com Australia
Relay Therapeutics CFO sells shares worth $44,246 - Investing.com Australia
Relay Therapeutics chief legal officer sells $44,040 in stock - Investing.com
Relay Therapeutics Executives Sell Shares to Cover Tax Obligations and Under Trading Plan - TradingView
Healthy Upside Potential: Relay Therapeutics Inc (RLAY) - Sete News
17.27%
1.06%
자본화:
|
볼륨(24시간):